Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis
Yahoo
Friday, April 5, 2013 - 11:41am
tags:
Neuralstem, patents, stem cells, ALS, Lou Gehrig's disease
Defibrillator lawsuit could re-expose device makers to litigation: WSJ
Marketwatch
Friday, April 5, 2013 - 11:15am
tags:
defibrillators, devices, St. Jude Medical, Medtronic, Boston Scientific
Clawing Back Money From Pharma Execs Over Bad Behavior
Pharmalot
Friday, April 5, 2013 - 11:13am
tags:
executive pay
Astex Pharmaceuticals: A Catalyst-Driven Year Ahead
Seeking Alpha
Friday, April 5, 2013 - 11:11am
tags:
Astex, SG-110, Celgene
Orphan Status for Insmed's Arikace
Yahoo/Zacks
Friday, April 5, 2013 - 11:10am
tags:
Arikace, orphan drugs, Insmed, non-tuberculous mycobacteria
Obagi Bidding War Seen Pushing Premium to 99%: Real M&A
Bloomberg
Friday, April 5, 2013 - 11:08am
tags:
Obagi Medical Products, Valeant Pharmaceuticals, Merz, M&A
Positive Data on Repros' Androxal
Yahoo/Zacks
Friday, April 5, 2013 - 11:07am
tags:
Repros Therapeutics, Androxal, secondary hypogonadism
Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab
Reuters
Friday, April 5, 2013 - 11:06am
tags:
Emergent BioSolutions, rituximab, TRU-016, CLL
Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
Yahoo
Friday, April 5, 2013 - 11:05am
tags:
Arena Pharmaceuticals, autoimmune disease, APD334
Inovio's Hepatitis C Data: What Does It Really Mean?
Seeking Alpha
Friday, April 5, 2013 - 11:04am
tags:
Inovio, hepatitis C, ChronTech AB, ChronVac-C, vaccines
Pozen announces results of sponsored study on cardiovascular disease
Yahoo/Fly on the Wall
Friday, April 5, 2013 - 10:51am
tags:
Pozen, cardiovascular disease, Xcenda
Strength In Sucampo Heading Into FDA Decision And Analyst Activity
Seeking Alpha
Friday, April 5, 2013 - 10:50am
tags:
Sucampo, FDA, Rescula, Amitiza, opioid-induced constipation
Florida Senate committee passes biosimilar bill
Drug Store News
Friday, April 5, 2013 - 10:47am
tags:
Florida, biosimilars
Judge Rules Morning After Pill Restrictions Should Be Lifted
Pharmalot
Friday, April 5, 2013 - 10:46am
tags:
Plan B contraceptive, FDA
Sarepta's Eteplirsen Boys Keep On Walking
TheStreet.com
Friday, April 5, 2013 - 10:45am
tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
Pfizer's Oncology Division Gets A Boost With European Approval For Bosulif
Seeking Alpha
Friday, April 5, 2013 - 10:26am
tags:
Pfizer, oncology, Bosulif, CML
Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir
Yahoo/Fly on the Wall
Friday, April 5, 2013 - 10:25am
tags:
VX-135, Vertex Pharmaceuticals, Bristol-Myers Squibb, daclatasvir, hepatitis C
A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation
Seeking Alpha
Friday, April 5, 2013 - 10:23am
tags:
Pfizer, JNJ, GSK, Abbott Laboratories, Merck, Novartis
AstraZeneca, Rigel arthritis pill disappoints again
Reuters
Friday, April 5, 2013 - 10:22am
tags:
Rigel, AstraZeneca, fostamatinib, rheumatoid arthritis
3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool
Friday, April 5, 2013 - 10:21am
tags:
Merck, Endocyte, Eli Lilly, Pfizer, Repligen, AbbVie, Protalix BioTherapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.